Clinical Trials in Nashville

Showing 9281-9300 of 20,298 trials

Efficacy and Safety of SYNB1618 and SYNB1934 in Adult Patients With Phenylketonuria

NCT04534842

This Phase 2 study in patients with phenylketonuria (PKU) will be an open-label, dual-arm study of either a SYNB1618 or SYNB1934 dose-ramp regimen. All evaluations and assessments throughout this study may be conducted either at the clinical site or by a home healthcare professional at an alternative location (e.g., patient's home, hotel).

Phenylketonuria

Synlogic20 participantsStarted Aug 2020

Aurora, Colorado, United States • Boca Raton, Florida, United States • Gainesville, Florida, United States +8 more locations

COMPLETEDPhase 2< 1 mile

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis

NCT03486912

This is a study of experimental medication BMS-986036 given to adults with Nonalcoholic Steatohepatitis (NASH; the buildup of fat and inflammation in the liver that is not caused by alcohol) and liver cirrhosis (liver damage characterized by normal liver tissue being replaced by scar tissue).

Hepatic CirrhosisLiver FibrosisNonalcoholic Fatty Liver Disease (NAFLD)+1 more

Bristol-Myers Squibb155 participantsStarted Jun 2018

Madison, Alabama, United States • Chandler, Arizona, United States • Phoenix, Arizona, United States +88 more locations

Efficacy and Safety of SYNB1618 and SYNB1934 in Adult Patients With Phenylketonuria

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis

Find Trials by Condition in Nashville

A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention

Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention

A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.

Elderberry for Immune Support

Extracorporeal CO2 Removal With the Hemolung RAS for Mechanical Ventilation Avoidance During Acute Exacerbation of COPD

An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis

Post-market Assessment of Biodesign Dural Repair Grafts

Clinical Performance of Two Daily Disposable Toric Soft Contact Lenses

Safety and Effectiveness Study of the Reflection Ceramic Acetabular System

Open-Label Safety Study of AXS-05 in Subjects With Depression

A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia

Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)

Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer

Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma

Clot Dissolving Treatment for Blood Clots in the Lungs

A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)

A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab

Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine Tumour